ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

KAREN CONNALLY-FRANK DO

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,287Medicare Part D Prescriptions Filled, Including Refills

Rank: 180 out of 910

$581K Total Retail Price of All Prescriptions

Rank: 120 out of 910

628 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 628 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

9% of this provider’s 628 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,653 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
SIMVASTATIN 481 443 1 3
LEVOTHYROXINE SODIUM 469 443 2 1
LISINOPRIL 393 367 3 2
AMLODIPINE BESYLATE 318 310 4 4
OMEPRAZOLE 241 207 5 5
METOPROLOL SUCCINATE 225 220 6 21
LOSARTAN POTASSIUM 184 170 7 15
HYDROCODONE-ACETAMINOPHEN 167 159 S3 8 8
METFORMIN HCL 166 157 9 6
HYDROCHLOROTHIAZIDE 159 150 10 12
CRESTOR 157 141 11 26
METOPROLOL TARTRATE 152 148 12 7
WARFARIN SODIUM 152 150 12 11
CITALOPRAM HBR 148 134 14 19
TRAMADOL HCL 144 118 15 25
ZOLPIDEM TARTRATE 131 115 16 17
GABAPENTIN 129 121 17 13
ALENDRONATE SODIUM 117 113 18 22
ATENOLOL 104 95 19 10
FUROSEMIDE 98 96 20 9
TRIAMTERENE-HCTZ 90 88 21 39
FLUTICASONE PROPIONATE 86 86 22 23
POTASSIUM CHLORIDE 68 68 23 18
CLOPIDOGREL 65 59 24 35
PANTOPRAZOLE SODIUM 65 59 24 27
DIOVAN 62 59 26 34
LOVASTATIN 61 61 27 20
ESTRADIOL 59 30 R 28 92
SINGULAIR 58 54 29 144
CIPROFLOXACIN HCL 58 56 29 48
PAROXETINE HCL 57 57 31 50
HYDRALAZINE HCL 55 55 32 65
SERTRALINE HCL 52 42 33 24
OXYBUTYNIN CHLORIDE ER 51 51 34 111
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.